首页> 美国卫生研究院文献>other >Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery

【2h】

Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery

机译：序贯联合治疗与单药治疗：炎症性肠病相关手术缺乏及时性。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe benefits of combination therapy with infliximab and azathioprine have been demonstrated in clinical trials of patients with ulcerative colitis (UC) and Crohn's disease (CD). Concerns remain regarding the ideal duration and benefits of adding therapies in a sequential manner.

机译：背景技术英夫利昔单抗和硫唑嘌呤联合治疗的益处已在溃疡性结肠炎（UC）和克罗恩病（CD）患者的临床试验中得到证明。依序添加疗法的理想持续时间和益处仍然令人担忧。

著录项

期刊名称 other
作者
Edward L. Barnes; Alison Goldin; Rachel W. Winter; Emily Collins; Bonnie Cao; Madeline Carrellas; Anne Marie Crowell; Joshua R. Korzenik;
展开▼
作者单位

展开▼
年(卷),期 -1(61),11
年度 -1
页码 3261–3269
总页数 15
原文格式 PDF
正文语种
中图分类
关键词
Inflammatory bowel disease Combination therapy Infliximab Adalimumab Azathioprine;

机译：炎症性肠病;联合治疗;英夫利昔单抗;阿达木单抗;硫唑嘌呤;

相似文献

外文文献
中文文献
专利

1. Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery [J] . Barnes Edward L., Goldin Alison, Winter Rachel W., Digestive Diseases and Sciences . 2016,第11期

机译：序贯联合治疗与单药治疗：炎症性肠病相关手术缺乏及时性。
2. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study [J] . Targownik Laura E., Benchimol Eric I., Bernstein Charles N., Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2019,第9期

机译：与单一疗法相比，前期组合治疗，用于先前未治疗生物药剂的患者，生物剂伴侣在群体的队列研究中降低炎症性肠病疾病相关并发症的风险
3. Patient-Specific Approach to Combination Versus Monotherapy with the Use of Antitumor Necrosis Factor α Agents for Inflammatory Bowel Disease [J] . DevlinS.M., CheifetzA.S., SiegelC.A. Gastroenterology Clinics of North America . 2012,第2期

机译：结合抗肿瘤坏死因子α药物治疗炎症性肠病的患者特定方法与单药联合治疗
4. Inflammatory bowel disease-related cancer - just the same as sporadic? -Pro [C] . J. M. RHODE Falk Symposium . 2007

机译：炎症性肠病相关癌症 - 与零星一样，与零星一样-Pro.
5. The evaluation of anti-cancer effects of FL118 in retinoblastoma in monotherapy and combination therapies. [D] . Singh, Jasman Kaur. 2014

机译：在单一疗法和联合疗法中评估FL118在视网膜母细胞瘤中的抗癌作用。
6. Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy? [O] . Nicolas Williet, Xavier Roblin 2017

机译：炎性肠病患者单一治疗降低硫唑嘌呤剂量的趋势：联合治疗如何？
7. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study [O] . Laura E. Targownik, Eric I. Benchimol, Charles N. Bernstein, 2019

机译：与单一疗法相比，前期组合治疗，用于先前未治疗生物药剂的患者，生物剂伴侣在群体的队列研究中降低炎症性肠病疾病相关并发症的风险
8. Studies of Ocular Complications of AIDS (SOCA): Database Documentation for'Combination Foscarnet and Ganciclovir Therapy versus Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients with AIDS (CRRT)' [R] . 1997

机译：艾滋病眼部并发症（sOCa）研究：“联合膦甲酸和更昔洛韦治疗与单药治疗艾滋病患者复发性巨细胞病毒性视网膜炎（CRRT）”的数据库文件

Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery

摘要

著录项

相似文献

相关主题

期刊订阅